To investigate the role of αTIGIT + bintrafusp alfa combination treatment on host cytokine production, serum was collected from MC38-CEA tumor-bearing mice prior to tumor instillation, and at indicated times throughout the course of treatment with αTIGIT and bintrafusp alfa (Figure 5). This evidence concerns the gene CEACAM5 and neoplasm.